Zonegran and Ergocalciferol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zonegran (zonisamide) and Ergocalciferol (ergocalciferol). Common drug interactions include bipolar disorder among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Zonegran and Ergocalciferol. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Zonegran?

Zonegran has active ingredients of zonisamide. It is often used in epilepsy. eHealthMe is studying from 6,211 Zonegran users. Check the latest studies of Zonegran.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.

On Jul, 14, 2026

32 people who take Zonegran and Ergocalciferol together, and have interactions are studied.

Zonegran and Ergocalciferol drug interactions.

What are the common drug interactions of Zonegran and Ergocalciferol, by gender? *:

female:

Bipolar disorder (mood disorder)
Endometrial cancer
Restless legs syndrome (a powerful urge to move your legs)
Weight increased
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Urinary tract infection
Drug effect decreased
Hospitalisation
Hypokalaemia (low potassium)
Impaired work ability

male:

Headache (pain in head)
Back injury
Intervertebral disc protrusion (spinal disc protrusion)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Insomnia (sleeplessness)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Decreased appetite
Fall

What are the common drug interactions of Zonegran and Ergocalciferol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Hypotonia (low muscle tone)

20-29:

Back injury
Headache (pain in head)
Insomnia (sleeplessness)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)

30-39:

Bipolar disorder (mood disorder)
Endometrial cancer
Restless legs syndrome (a powerful urge to move your legs)
Weight increased
Drug effect decreased
Alopecia (absence of hair from areas of the body)
Headache (pain in head)
Insomnia (sleeplessness)
Lethargy (tiredness)
Nausea (feeling of having an urge to vomit)

40-49:

Hypokalaemia (low potassium)

50-59:

Impaired work ability
Restless legs syndrome (a powerful urge to move your legs)
Weight increased
Decreased appetite
Nausea (feeling of having an urge to vomit)
Hospitalisation
Hypokalaemia (low potassium)
Bipolar disorder (mood disorder)
Drug effect decreased
Endometrial cancer

60+:

Decreased interest
Depressed mood
Fall
Head injury
Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 50.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 31.25%
Migraine (headache): 3 people, 9.38%
Headache (pain in head): 3 people, 9.38%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 6.25%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.25%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.25%
Drowsiness: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Zonegran and Ergocalciferol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously